ATACH Calls on the FDA & Congress to Regulate Non-intoxicating CBD and to Address Unregulated Hemp Synthesized Intoxicating Products following Congressional Subcommittee Hearing
Today, following the House Oversight Committee’s Subcommittee on Health Care and Financial Services hearing titled, “Hemp in the Modern World: The Yearslong Wait for FDA Action,” the American Trade Association for Cannabis and Hemp (ATACH), pressed for the case for a discussion on hemp synthesized intoxicants. Said ATACH President Michael Bronstein: “While we commend the […]